DK
Insider
Douglas F Kling
Chief Operating OfficerDouglas F Kling (Chief Operating Officer) filed 9 Form 4 reports in the past 24 months (0 purchases, 9 sales), most often in NewAmsterdam Pharma Company N.V. (NAMS). The largest single filing was $2.9M of NAMS (129,559 sh across 4 lots, as filed), executed Jan 27 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
9
0 buys · 9 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$16.5M
shares × price, as filed
Last traded
Jul 16 2025
Filed Jul 17 2025
Median ADV $32.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $16.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
9 filings
Sector per market data · by filing · past 24 months
Most traded names
NAMSRecent filings
NAMSSALE
NewAmsterdam Pharma Company N.V.
View filing →
$2.0M95,068 sh across 2 lots
Exec Jul 15 2025
Filed Jul 17 2025 · 5:30 PM ET NAMSSALE NewAmsterdam Pharma Company N.V. View filing → $1.9M
100,000 sh across 2 lots
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET NAMSSALE NewAmsterdam Pharma Company N.V. View filing → $1.9M
as filed
Exec May 15 2025
Filed May 19 2025 · 5:30 PM ET NAMSSALE NewAmsterdam Pharma Company N.V. View filing → $1.6M
as filed
Exec Apr 15 2025
Filed Apr 17 2025 · 5:30 PM ET NAMSSALE NewAmsterdam Pharma Company N.V. View filing → $373K
as filed
Exec Mar 26 2025
Filed Mar 28 2025 · 5:30 PM ET NAMSSALE NewAmsterdam Pharma Company N.V. View filing → $2.3M
as filed
Exec Mar 17 2025
Filed Mar 19 2025 · 5:30 PM ET NAMSSALE NewAmsterdam Pharma Company N.V. View filing → $2.0M
100,000 sh across 2 lots
Exec Feb 18 2025
Filed Feb 20 2025 · 5:30 PM ET NAMSSALE NewAmsterdam Pharma Company N.V. View filing → $1.5M
70,441 sh across 3 lots
Exec Jan 29 2025
Filed Jan 31 2025 · 5:30 PM ET More filings →